In the realm of radiopharmaceuticals, Perspective Therapeutics is making waves, ushering in a new era of cancer treatment with their groundbreaking molecule, [212Pb]VMT-α-NET. This sleek peptide-guided, lead-based therapy is engineered to target and treat neuroendocrine tumors (NETs) in a pioneering fashion, using a radioactive payload to bombard tumor cells with alpha particles. The innovative tactic, […]